Please assess the completion status of the following clinical trial:

Trial Title: Ivermectin in the Treatment of Head Lice

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Head lice infestation confirmed by detection combing by study staff~* previous (within 6 weeks) use of a topical insecticide product~* minimum 15kg weight~* providing informed consent~Exclusion Criteria:~* pregnant or nursing patients~* households with 7 or more infested patients~* households where there are other known infested household members not participating~* head lice treatment within 2 weeks of entry~* active scalp infection~* any difficulty with combing assessment~* patient from region endemic for certain parasitic worm diseases

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ivermectin (Type: EXPERIMENTAL): ivermectin Stromectol®)
- Malathion (Type: ACTIVE_COMPARATOR): malathion(Prioderm®)

Based on this trial design, predict the completion outcome and termination type (if applicable).